🇺🇸 FDA
Patent

US 7201902

Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection

granted A61KA61K2039/53A61K39/00

Quick answer

US patent 7201902 (Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection) held by United States of America as represented by the Secretary of the Air Force expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/53, A61K39/00